Quick Takeaways
- WASATCH ADVISORS LP filed SCHEDULE 13G/A for SANGAMO THERAPEUTICS, INC Common Stock (SGMO).
- Disclosed ownership: 6.6%.
- Date of event: 31 Dec 2024.
WASATCH ADVISORS LP - 31 Dec 2024 SCHEDULE 13G/A Report for SANGAMO THERAPEUTICS, INC Common Stock (SGMO)
- Filing Manager
- WASATCH ADVISORS LP
- Reporting Manager
- WASATCH ADVISORS LP
- Symbol
- SGMO
- Shares outstanding
- 212,021,364 shares
- Disclosed Ownership
- 13,993,410 shares
- Ownership
- 6.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Jan 2025, 18:47:23 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 12 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"WASATCH ADVISORS LP disclosed 6.6% ownership in SANGAMO THERAPEUTICS, INC Common Stock (SGMO) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Jan 2025, 18:47.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| WASATCH ADVISORS LP | 6.6% | 13,993,410 | 13,993,410 | 0 | JB Taylor | JB Taylor/CEO |